Cargando…

Parkinson’s disease and cancer: a systematic review and meta-analysis of over 17 million participants

OBJECTIVE: To systematically review and qualitatively evaluate epidemiological evidence on associations between Parkinson’s disease (PD) and cancer via meta-analysis. DATA SOURCES: MEDLINE via PubMed, Web of Science and EMBASE, until March 2021. STUDY SELECTION: Included were publications that (1) w...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Xinyuan, Guarin, David, Mohammadzadehhonarvar, Niyaz, Chen, Xiqun, Gao, Xiang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8256737/
https://www.ncbi.nlm.nih.gov/pubmed/34215604
http://dx.doi.org/10.1136/bmjopen-2020-046329
_version_ 1783718157429506048
author Zhang, Xinyuan
Guarin, David
Mohammadzadehhonarvar, Niyaz
Chen, Xiqun
Gao, Xiang
author_facet Zhang, Xinyuan
Guarin, David
Mohammadzadehhonarvar, Niyaz
Chen, Xiqun
Gao, Xiang
author_sort Zhang, Xinyuan
collection PubMed
description OBJECTIVE: To systematically review and qualitatively evaluate epidemiological evidence on associations between Parkinson’s disease (PD) and cancer via meta-analysis. DATA SOURCES: MEDLINE via PubMed, Web of Science and EMBASE, until March 2021. STUDY SELECTION: Included were publications that (1) were original epidemiological studies on PD and cancer; (2) reported risk estimates; (3) were in English. Exclusion criteria included: (1) review/comments; (2) biological studies; (3) case report/autopsy studies; (4) irrelevant exposure/outcome; (5) treated cases; (6) no measure of risk estimates; (7) no confidence intervals/exact p values and (8) duplicates. DATA EXTRACTION AND SYNTHESIS: PRISMA and MOOSE guidelines were followed in data extraction. Two-step screening was performed by two authors blinded to each other. A random-effects model was used to calculate pooled relative risk (RR). MAIN OUTCOMES AND MEASURES: We included publications that assessed the risk of PD in individuals with vs without cancer and the risk of cancer in individuals with vs without PD. RESULTS: A total of 63 studies and 17 994 584 participants were included. Meta-analysis generated a pooled RR of 0.82 (n=33; 95% CI 0.76 to 0.88; p<0.001) for association between PD and total cancer, 0.76 (n=21; 95% CI 0.67 to 0.85; p<0.001) for PD and smoking-related cancer and 0.92 (n=19; 95% CI 0.84 to 0.99; p=0.03) for non-smoking-related cancer. PD was associated with an increased risk of melanoma (n=29; pooled RR=1.75; 95% CI 1.43 to 2.14; p<0.001) but not for other skin cancers (n=17; pooled RR=0.90; 95% CI 0.60 to 1.34; p=0.60). CONCLUSIONS: PD and total cancer were inversely associated. This inverse association persisted for both smoking-related and non-smoking-related cancers. PD was positively associated with melanoma. These results provide evidence for further investigations for possible mechanistic associations between PD and cancer. PROSPERO REGISTRATION NUMBER: CRD42020162103.
format Online
Article
Text
id pubmed-8256737
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher BMJ Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-82567372021-07-30 Parkinson’s disease and cancer: a systematic review and meta-analysis of over 17 million participants Zhang, Xinyuan Guarin, David Mohammadzadehhonarvar, Niyaz Chen, Xiqun Gao, Xiang BMJ Open Epidemiology OBJECTIVE: To systematically review and qualitatively evaluate epidemiological evidence on associations between Parkinson’s disease (PD) and cancer via meta-analysis. DATA SOURCES: MEDLINE via PubMed, Web of Science and EMBASE, until March 2021. STUDY SELECTION: Included were publications that (1) were original epidemiological studies on PD and cancer; (2) reported risk estimates; (3) were in English. Exclusion criteria included: (1) review/comments; (2) biological studies; (3) case report/autopsy studies; (4) irrelevant exposure/outcome; (5) treated cases; (6) no measure of risk estimates; (7) no confidence intervals/exact p values and (8) duplicates. DATA EXTRACTION AND SYNTHESIS: PRISMA and MOOSE guidelines were followed in data extraction. Two-step screening was performed by two authors blinded to each other. A random-effects model was used to calculate pooled relative risk (RR). MAIN OUTCOMES AND MEASURES: We included publications that assessed the risk of PD in individuals with vs without cancer and the risk of cancer in individuals with vs without PD. RESULTS: A total of 63 studies and 17 994 584 participants were included. Meta-analysis generated a pooled RR of 0.82 (n=33; 95% CI 0.76 to 0.88; p<0.001) for association between PD and total cancer, 0.76 (n=21; 95% CI 0.67 to 0.85; p<0.001) for PD and smoking-related cancer and 0.92 (n=19; 95% CI 0.84 to 0.99; p=0.03) for non-smoking-related cancer. PD was associated with an increased risk of melanoma (n=29; pooled RR=1.75; 95% CI 1.43 to 2.14; p<0.001) but not for other skin cancers (n=17; pooled RR=0.90; 95% CI 0.60 to 1.34; p=0.60). CONCLUSIONS: PD and total cancer were inversely associated. This inverse association persisted for both smoking-related and non-smoking-related cancers. PD was positively associated with melanoma. These results provide evidence for further investigations for possible mechanistic associations between PD and cancer. PROSPERO REGISTRATION NUMBER: CRD42020162103. BMJ Publishing Group 2021-07-02 /pmc/articles/PMC8256737/ /pubmed/34215604 http://dx.doi.org/10.1136/bmjopen-2020-046329 Text en © Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY. Published by BMJ. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution 4.0 Unported (CC BY 4.0) license, which permits others to copy, redistribute, remix, transform and build upon this work for any purpose, provided the original work is properly cited, a link to the licence is given, and indication of whether changes were made. See: https://creativecommons.org/licenses/by/4.0/.
spellingShingle Epidemiology
Zhang, Xinyuan
Guarin, David
Mohammadzadehhonarvar, Niyaz
Chen, Xiqun
Gao, Xiang
Parkinson’s disease and cancer: a systematic review and meta-analysis of over 17 million participants
title Parkinson’s disease and cancer: a systematic review and meta-analysis of over 17 million participants
title_full Parkinson’s disease and cancer: a systematic review and meta-analysis of over 17 million participants
title_fullStr Parkinson’s disease and cancer: a systematic review and meta-analysis of over 17 million participants
title_full_unstemmed Parkinson’s disease and cancer: a systematic review and meta-analysis of over 17 million participants
title_short Parkinson’s disease and cancer: a systematic review and meta-analysis of over 17 million participants
title_sort parkinson’s disease and cancer: a systematic review and meta-analysis of over 17 million participants
topic Epidemiology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8256737/
https://www.ncbi.nlm.nih.gov/pubmed/34215604
http://dx.doi.org/10.1136/bmjopen-2020-046329
work_keys_str_mv AT zhangxinyuan parkinsonsdiseaseandcancerasystematicreviewandmetaanalysisofover17millionparticipants
AT guarindavid parkinsonsdiseaseandcancerasystematicreviewandmetaanalysisofover17millionparticipants
AT mohammadzadehhonarvarniyaz parkinsonsdiseaseandcancerasystematicreviewandmetaanalysisofover17millionparticipants
AT chenxiqun parkinsonsdiseaseandcancerasystematicreviewandmetaanalysisofover17millionparticipants
AT gaoxiang parkinsonsdiseaseandcancerasystematicreviewandmetaanalysisofover17millionparticipants